Published on 10/14/2015 in the Prospect News Structured Products Daily.
New Issue: JPMorgan prices $503,000 autocallable reverse exchangeables linked to Gilead Sciences
By Angela McDaniels
Tacoma, Wash., Oct. 14 – JPMorgan Chase & Co. priced $503,000 of 7.75% autocallable reverse exchangeable notes due Oct. 17, 2016 linked to the common stock of Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
Interest is payable monthly.
The notes will be called at par if Gilead Sciences stock closes at or above the initial share price on April 11, 2016 or July 11, 2016.
If the notes are not called, the payout at maturity will be par unless the final share price is less than the initial share price and the stock closes below the trigger price, 65% of the initial share price, on any day during the life of the notes, in which case the payout will be a number of Gilead Sciences shares equal to $1,000 divided by the initial share price or, at the issuer’s option, an amount in cash equal to the value of those shares.
J.P. Morgan Securities LLC is the agent.
Issuer: | JPMorgan Chase & Co.
|
Issue: | Autocallable reverse exchangeable notes
|
Underlying stock: | Gilead Sciences, Inc. (Symbol: GILD)
|
Amount: | $503,000
|
Maturity: | Oct. 17, 2016
|
Coupon: | 7.75%, payable monthly
|
Price: | Par
|
Payout at maturity: | Par unless final share price is less than initial share price and stock closes below trigger price on any day during life of notes, in which case 9.9354 Gilead Sciences shares or cash amount equal to value of those shares
|
Call: | At par if stock closes at or above initial share price on April 11, 2016 or July 11, 2016
|
Initial share price: | $100.65
|
Trigger value: | $65.422, 65% of initial share price
|
Pricing date: | Oct. 9
|
Settlement date: | Oct. 14
|
Agent: | J.P. Morgan Securities LLC
|
Fees: | 1.5%
|
Cusip: | 46625HNP1
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.